Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Harmony Biosciences Holdings (HRMY) Equity Ratio (2019 - 2025)

Historic Equity Ratio for Harmony Biosciences Holdings (HRMY) over the last 7 years, with Q3 2025 value amounting to 0.69.

  • Harmony Biosciences Holdings' Equity Ratio rose 749.41% to 0.69 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.69, marking a year-over-year increase of 749.41%. This contributed to the annual value of 0.66 for FY2024, which is 1462.69% up from last year.
  • According to the latest figures from Q3 2025, Harmony Biosciences Holdings' Equity Ratio is 0.69, which was up 749.41% from 0.7 recorded in Q2 2025.
  • Harmony Biosciences Holdings' 5-year Equity Ratio high stood at 0.7 for Q2 2025, and its period low was 0.32 during Q1 2021.
  • For the 5-year period, Harmony Biosciences Holdings' Equity Ratio averaged around 0.56, with its median value being 0.61 (2024).
  • In the last 5 years, Harmony Biosciences Holdings' Equity Ratio surged by 8909.91% in 2021 and then tumbled by 372.92% in 2023.
  • Harmony Biosciences Holdings' Equity Ratio (Quarter) stood at 0.43 in 2021, then skyrocketed by 38.93% to 0.6 in 2022, then dropped by 3.73% to 0.58 in 2023, then rose by 14.63% to 0.66 in 2024, then grew by 4.78% to 0.69 in 2025.
  • Its Equity Ratio stands at 0.69 for Q3 2025, versus 0.7 for Q2 2025 and 0.68 for Q1 2025.